Meridian Bioscience Inc. (VIVO) Social Stream

Meridian Bioscience Inc. (VIVO): $32.92

-0.08 (-0.24%)

POWR Rating

Component Grades













Meridian Bioscience Inc (VIVO) Price Targets From Analysts

Use the tables below to see what analysts covering Meridian Bioscience Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-08 2 $27 $27 $27 $26.27 2.78%
2021-11-15 2 $28 $28 $28 $26.27 6.59%
2022-02-07 2 $30 $30 $30 $26.27 14.2%

The Trend in the Analyst Price Target

Over the past 21 months, VIVO's average price target has gone up $11.

VIVO reports an average of 43.7% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 2 34 32 32.67 20.45 59.76%
2021-06-13 2 34 25 29.67 20.65 43.68%
2021-08-05 2 34 25 29.67 21.33 39.1%
2021-08-28 2 34 25 28.67 20.01 43.28%
2021-09-04 2 34 25 28.67 20.48 39.99%

VIVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations

VIVO's average broker recommendation rating improved by 0 over the prior 18 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Meridian Bioscience Inc's variance in analysts' estimates is lower than just about 100% of them.
  • Meridian Bioscience Inc's number of analysts covering the stock is higher than 14.07% of Healthcare stocks.
  • In the context of Pharmaceutical Products stocks, Meridian Bioscience Inc's upside potential (average analyst target price relative to current price) is higher than 17.59% of them.
  • In the context of stocks in the small market cap category, Meridian Bioscience Inc's average analyst price target is greater than 193.31% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Meridian Bioscience Inc are TRIB, TKNO, and QTNT.

What is the outlook for VIVO? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.534 seconds.